DELIVERY SYSTEMS for MESSENGER RNA
Messenger RNA (mRNA) therapy has been developed as an alternative to DNA-based therapies as it avoids several limiting issues associated with the DNA delivery. It can efficiently modify hard-to-transfect non-diving cells since it does not require entry into the nuclear compartment, and avoids the risk of permanent integration of foreign material into the host genome.
Despite the promise of a wide range of therapeutic applications, the critical issue with mRNA delivery is now deployment by an effective delivery system. RJH Biosciences is dedicated to developing safe and effective nucleic acid delivery systems, including mRNA-Fect, which has been optimized for mRNA delivery to a variety of call lines and primary cells.
Transfecting Attachment-Dependent and Suspension-Growing Cells with mRNA-Fect
Anticancer Activity of mRNA-Fect/TRAIL-mRNA Treatment in Breast Cancer Cells
TRANSFECTION REAGENTS NOW AVAILABLE AT NO COST FOR COVID-19 RESEARCH & DEVELOPMENT
RJH Biosciences Inc. is currently offering their transfection reagents and delivery systems to COVID-19 researchers worldwide at no cost (plus shipping). Please contact us directly for more information regarding this initiate.
"We hope that our reagents can be widely explored to better understand this disease and leave no stones unturned in the search for a cure"
For assistance in choosing the appropriate reagent, please refer to our selection guide.
mRNA-Fect: mRNA Transfection Reagent
• For attachment-dependent and suspension growing cells such as primary stem cells, immune cells (primary and cell lines) and various cancer cell lines
• Optimized for mRNA transfection in transient protein expression
WE ARE HAPPY TO HELP!
Get personalized advice by an RJH representative on the best transfection methods for a specific application. We look forward to working with you soon.